FireCyte Therapeutics
FireCyte Therapeutics is a biotech company in Beverly, United States, founded in 2022. It has raised $12.0M across 2 rounds, most recently a $5.5M Venture Round in January 2022.
- Headquarters
- Beverly, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- firecyte.com
- Total Funding
- $12.0M
- Last Round
- $5.5M Venture RoundJan 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Neuroscience-based ophthalmology company developing multi-target intravitreal anti-inflammatory proteins.
Summary
It lists 1–10 employees. It has raised $12.0M in total across 2 rounds, most recently a $5.5M Venture Round in Jan 2022. Investors include Morningside Group, AbbVie Ventures and Mass General Brigham Ventures.
Funding History
Jan 2022
Sign up to see all 2 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/firecyte-therapeutics"><img src="https://indexed.vc/api/badge/company/firecyte-therapeutics" alt="FireCyte Therapeutics on Indexed.vc" width="260" height="76" /></a>